133 related articles for article (PubMed ID: 31935808)
1. Effect of Formulation Factors and Oxygen Levels on the Stability of Aqueous Injectable Solution Containing Pemetrexed.
Won DH; Park H; Ha ES; Kim YM; Hwang HD; Jang SW; Kim MS
Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31935808
[TBL] [Abstract][Full Text] [Related]
2. Effect of Packaging Materials and the Leached Iron on the Stability of Butorphanol Tartrate Injection.
Dai Z; Zhu C; Liu C; Lyu J; Xu J; Wu H; Zhang F
AAPS PharmSciTech; 2021 Jun; 22(5):186. PubMed ID: 34145510
[TBL] [Abstract][Full Text] [Related]
3. Developing an injectable formula containing an oxygen-sensitive drug: a case study of danofloxacin injectable.
Kasraian K; Kuzniar AA; Wilson GG; Wood JA
Pharm Dev Technol; 1999; 4(4):475-80. PubMed ID: 10578500
[TBL] [Abstract][Full Text] [Related]
4. Influence of formulation properties on chemical stability of captopril in aqueous preparations.
Kristensen S; Lao YE; Brustugun J; Braenden JU
Pharmazie; 2008 Dec; 63(12):872-7. PubMed ID: 19177902
[TBL] [Abstract][Full Text] [Related]
5. Formulation of a stable parenteral product; Clonidine Hydrochloride Injection.
Kostecka D; Duncan MR; Wagenknecht D
PDA J Pharm Sci Technol; 1998; 52(6):320-5. PubMed ID: 10050130
[TBL] [Abstract][Full Text] [Related]
6. Determination of the Degradation Chemistry of the Antitumor Agent Pemetrexed Disodium.
Jansen PJ; Smith WK; Baertschi SW; Dorman DE; Kemp CAJ; McCune KA
J Pharm Sci; 2016 Nov; 105(11):3256-3268. PubMed ID: 27539558
[TBL] [Abstract][Full Text] [Related]
7. A strategy for the prevention of protein oxidation by drug product in polymer-based syringes.
Nakamura K; Abe Y; Kiminami H; Yamashita A; Iwasaki K; Suzuki S; Yoshino K; Dierick W; Constable K
PDA J Pharm Sci Technol; 2015; 69(1):88-95. PubMed ID: 25691717
[TBL] [Abstract][Full Text] [Related]
8. Degradation pathways of 4-methylmethcathinone in alkaline solution and stability of methcathinone analogs in various pH solutions.
Tsujikawa K; Mikuma T; Kuwayama K; Miyaguchi H; Kanamori T; Iwata YT; Inoue H
Forensic Sci Int; 2012 Jul; 220(1-3):103-10. PubMed ID: 22402273
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the stability of linezolid in aqueous solution and commonly used intravenous fluids.
Taylor R; Sunderland B; Luna G; Czarniak P
Drug Des Devel Ther; 2017; 11():2087-2097. PubMed ID: 28744100
[TBL] [Abstract][Full Text] [Related]
10. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
11. Kinetics and mechanism of captopril oxidation in aqueous solution under controlled oxygen partial pressure.
Lee TY; Notari RE
Pharm Res; 1987 Apr; 4(2):98-103. PubMed ID: 3334413
[TBL] [Abstract][Full Text] [Related]
12. Use of an Oxygen Extractor to Minimize Oxidation of compounded Preparations.
Maget HJ
Int J Pharm Compd; 1999; 3(6):493-5. PubMed ID: 23985821
[TBL] [Abstract][Full Text] [Related]
13. Catalytic oxidation of calcium sulfite in solution/aqueous slurry.
Wu XQ; Wu ZB; Wang DH
J Environ Sci (China); 2004; 16(6):973-7. PubMed ID: 15900731
[TBL] [Abstract][Full Text] [Related]
14. Changes in the color, chemical stability and antioxidant capacity of thermally treated anthocyanin aqueous solution over storage.
Sui X; Bary S; Zhou W
Food Chem; 2016 Feb; 192():516-24. PubMed ID: 26304379
[TBL] [Abstract][Full Text] [Related]
15. Artifactual degradation of secondary amine-containing drugs during accelerated stability testing when saturated sodium nitrite solutions are used for humidity control.
Sluggett GW; Zelesky T; Hetrick EM; Babayan Y; Baertschi SW
J Pharm Biomed Anal; 2018 Feb; 149():206-213. PubMed ID: 29126082
[TBL] [Abstract][Full Text] [Related]
16. The aqueous stability of bupropion.
O'Byrne PM; Williams R; Walsh JJ; Gilmer JF
J Pharm Biomed Anal; 2010 Nov; 53(3):376-81. PubMed ID: 20547024
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant-accelerated oxidative degradation: a case study of transition metal ion catalyzed oxidation in formulation.
Hong J; Lee E; Carter JC; Masse JA; Oksanen DA
Pharm Dev Technol; 2004; 9(2):171-9. PubMed ID: 15202576
[TBL] [Abstract][Full Text] [Related]
18. Development of a stable solution of 5-aminolaevulinic acid for intracutaneous injection in photodynamic therapy.
de Blois AW; Grouls RJ; Ackerman EW; Wijdeven WJ
Lasers Med Sci; 2002; 17(3):208-15. PubMed ID: 12181635
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen production via photolytic oxidation of aqueous sodium sulfite solutions.
Huang C; Linkous CA; Adebiyi O; T-Raissi A
Environ Sci Technol; 2010 Jul; 44(13):5283-8. PubMed ID: 20515046
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches for improving stability of cysteamine formulations.
Dixon P; Powell K; Chauhan A
Int J Pharm; 2018 Oct; 549(1-2):466-475. PubMed ID: 30099213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
